Affiliation:
1. University of Hasselt
2. University of Antwerp, Hospital Network Antwerp (ZNA)
Abstract
Abstract
Background
arithmetic average values about disease burden across ageing adults are often used, which assumes homogeneity in group characteristics such as age, sex, disease frequency (incidence rates), and cost distributions. The question arises about how much outcome results such as overall cost obtained under this homogeneity assumption deviate from real-world population data that may manifest non-homogeneous distributions.
Methods
the method explores the amount of deviation measured between homogeneity versus non-homogeneity for overall infection costs in ageing adults as the outcome measure to assess. Population modelling is used with an extended sensitivity analysis plan (ESAP) that simulates non-homogeneous, age-specific distributional spread for demography, infectious disease, and its severity in people aged > 65 years old over a 1-year period in univariant and multivariant assessments. Costs are adjusted for 3 severity levels with increased difference between them using multiplication factors.
Results
the assumed full homogenous dataset systematically overestimates up to 10% the overall cost in ageing adults when compared with a group simulated with non-homogeneous distributions for age, infection, severity, and cost, mainly due to the demographic age-composition. Overall cost of a proposed homogeneous condition tends to underestimate the spending of non-homogeneous conditions when the reference case has a partial homogeneous set-up or when the demographic change in the non-homogeneous condition evolves towards age-demographic homogeneity (same number of people with increasing age), a likely evolution in the coming 10 to 20 years.
Conclusion
assessing the current cost burden of infectious diseases in ageing adults must consider exact age-composition of demography, infection spread with severity levels and their cost differences to avoid unrealistic cost estimates when assuming homogeneous group conditions.
Publisher
Research Square Platform LLC
Reference27 articles.
1. Design and interpretation of vaccine field studies;Halloran ME;Epidemiol Rev,1999
2. Measuring population ageing: an analysis of the Global Burden of Disease Study 2017;Chang AY;Lancet Public Health,2019
3. Ignoring population structure can lead to erroneous predictions of future population size;Tenhumberg B;Nat Educ Knowl,2010
4. The ageing of populations in Belgium: current situation and perspectives;Bourguignon M;Revue Quetelet,2017
5. Gilford D. The aging population in the Twenty-first century. Washington, DC: National Academy of Sciences; 1989.